Pharma RaaS

Research-as-a-Service · Full-scale computational biology pipelines · 7 therapeutic areas

7 Therapeutic AreasEnterprise TierReport export included
Oncology
CANCER

Neoantigen prediction, cancer driver variant analysis, tumor proteome screening.

GammaAlpha
Rare Disease
RARE

VUS pathogenicity scoring, ultra-rare variant structural impact, orphan drug target identification.

AlphaBeta
AMR / Infectious Disease
AMR

Multi-target beta-lactam docking, WHO Priority Pathogen structural analysis, resistance mechanism mapping.

BetaAlpha
Vaccine Design
VACCINE

Epitope mapping, antigen-antibody co-folding, cross-variant neutralisation prediction.

GammaAlpha
Neurodegeneration
NEURO

Amyloid/tau/α-synuclein aggregation inhibitor screening, fibril polymorph analysis.

AlphaBetaDelta
Cardiology
CARDIO

Ion channel variant analysis, PCSK9 / ApoB structural profiling, CardioRisk-India integration.

AlphaGamma
Pediatrics / Rare Genetics
PEDS

Congenital disorder variant interpretation, pediatric drug target structural analysis.

AlphaBeta
RaaS

How RaaS Works

Step 1
Submit target + disease context
→
Step 2
Surface 2 runs full ensemble pipeline
→
Step 3
Structured report delivered (PDF + JSON + DOCX)
→
Step 4
Optional: ongoing monitoring dashboard